Blog Posts

BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE & ABBVIE

Aug 3, 2023

Big Pharma Giants Boast Better Than Expected Q2 Earnings While Price-Gouging Read More

BIG PHARMA WATCH: COLOSSAL $81.9 BILLION IN 2022 EARNINGS FOR LARGEST DRUG MAKERS FUELED HUGE PROFITS

Jul 25, 2023

Top Five Drug Makers By U.S. Market Cap Plowed Soaring Earnings Into Stock Read More

BIG PHARMA WATCH: DRUG MAKER’S PRODUCT-HOPPING SCHEME BLOCKED ACCESS TO SAFER HIV MEDICATIONS TO JUICE PROFITS

Jul 24, 2023

The New York Times Exposes How Gilead Devised Egregious Patent Strategy to Read More

BIG PHARMA EARNINGS WATCH: NOVARTIS & JOHNSON & JOHNSON

Jul 20, 2023

Big Pharma Giants Kick Off Q2 Earnings On Heels of July Price Hikes This week, Read More

BIG PHARMA WATCH: HHS SECRETARY WARNS COVID-19 VACCINE MAKERS OVER “PRICE-GOUGING BEHAVIOR”

Jul 14, 2023

Becerra Encourages Manufacturers to Set “Reasonable” Prices on Upcoming Read More

BIG PHARMA WATCH: BIG PHARMA ALREADY INCREASING PRICES ON NEW RSV VACCINES TO BOOST PROFITS

Jul 13, 2023

Manufacturers Increasing Prices in Lockstep to Raise Prices Across New Drug Read More

BIG PHARMA WATCH: BIG PHARMA EXPOSED FOR CONTINUING TO HIKE PRICES FASTER THAN RATE OF INFLATION

Jun 16, 2023

HHS & CMS Announce New Penalties That Help Hold Brand Name Drug Companies Read More

DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS OVER $40 BILLION IN JUST ONE YEAR

May 23, 2023

New Analysis Highlights Urgency to Hold Big Pharma Accountable for Egregious Read More

DOSE OF REALITY: BIG PHARMA TAX AVOIDANCE PRACTICES COME UNDER SCRUTINY IN SENATE FINANCE HEARING

May 12, 2023

Report Finds Big Pharma Games the System to Avoid Paying U.S. Taxes While Read More

THEY SAID IT! LAWMAKERS SLAM BIG PHARMA CEOS FOR EGREGIOUS PRICING OF BRAND NAME INSULINS

May 12, 2023

Brand Name Drug Giants Refuse to Rule Out Future Insulin Price Hikes On Read More

DOSE OF REALITY: SENATORS MUST HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS INSULIN PRICING PRACTICES

May 9, 2023

Lawmakers Have Opportunity to Grill Big Pharma Executives on Tactics Like Read More

BIG PHARMA EARNINGS WATCH: PFIZER, MODERNA, ELI LILLY, NOVARTIS, GLAXOSMITHKLINE, ROCHE, AMGEN

May 9, 2023

Brand Name Drug Companies Continue to Hike Prices and Post Record Profits Read More